Clinical Research
Heart Rhythm Disorder: Editorial Comment
Lenient Versus Strict Rate Control in Atrial Fibrillation: Some Devils in the Details

https://doi.org/10.1016/j.jacc.2011.04.028Get rights and content
Under an Elsevier user license
open archive

Key Words

atrial fibrillation
atrial remodeling
rate control

Cited by (0)

Dr. Wyse has received honorarium from Boehringer Ingelheim, Medtronic, Bristol-Myers Squibb/Pfizer, sanofi-aventis, Biotronik, Merck, and Bayer.

Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.